Korea Arlico Pharm Co.,Ltd.

KOSDAQ:A260660 Voorraadrapport

Marktkapitalisatie: ₩58.5b

Korea Arlico PharmLtd Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Hang-Gu Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO39.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price

Aug 04
There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price

Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Mar 24
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Mar 02
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

Feb 12
Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Jan 25
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Jan 04
Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Dec 16
Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Nov 25
Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

CEO

Hang-Gu Lee (63 yo)

no data

Tenure

Mr. Hang-Gu Lee is Chief Executive Officer of Korea Arlico Pharm Co.,Ltd.